According to @business, Isomorphic Labs’ head of medicinal drug design Rebecca Paul said artificial intelligence is changing drug discovery and research and noted she sees a really exciting future where you don’t have to worry in an interview with Tom Mackenzie, source: @business. According to @business, the post shares qualitative executive commentary without disclosing trial data, timelines, revenues, partnerships, or regulatory milestones, so traders should treat this as sentiment rather than a concrete near-term catalyst, source: @business. According to @business, there are no explicit references to cryptocurrencies or blockchain, meaning any crypto impact would be narrative-only; traders in AI-related themes should note the absence of token or on-chain data in this clip, source: @business.